Early onset may predict G101W CDKN2A founder mutation carrier status in Ligurian melanoma patients
Year: 2004
Type: article
Study design: Observational Study
Source: Melanoma Research
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: National Cancer Institute
Award: G6019083953
OpenAlex ID: W2026376689
